Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vivo Bio Tech Ltd has submitted to BSE a monthly report from its Registrar and Share Transfer Agent (Aarthi Consultants Pvt Ltd) on the re-lodgement of physical share transfer requests, as required under a SEBI circular dated January 30, 2026. The report covers the period ended May 2026. All key metrics for the month—requests received, approved, rejected, and processed—are reported as NIL, with no separate processing time recorded. The filing is submitted by the Company Secretary and signed digitally on June 6, 2026.
This is a routine compliance filing with no material activity in physical share transfers during May 2026, so it is unlikely to affect the stock price or shareholder interests.